Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
J Cardiothorac Vasc Anesth. 2022 Jun;36(6):1662-1669. doi: 10.1053/j.jvca.2021.05.058. Epub 2021 Jul 2.
To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19).
Cross-sectional survey of a nationally representative sample.
Amazon Mechanical Turk platform.
In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a healthcare setting (22.5%) and having a friend or family member who was admitted to the hospital (43.8%) or died from COVID-19 (29.9%).
Although most reported an unwillingness to stay on ECMO for >one week without signs of recovery, participants were highly supportive of ECMO utilization as a life-preserving technique on a policy level. The majority (96.7%) advocated for continued use of ECMO to treat COVID patients during periods of resource scarcity but would prioritize those with highest likelihood of recovery (50%) followed by those who were sickest regardless of survival chances (31.7%). Patients >40 years old were more likely to prefer distributing ECMO on a first-come first-served basis (21.5% v 13.3%, p < 0.05).
Even though participants expressed hesitation regarding ECMO in personal circumstances, they were uniformly in support of using ECMO to treat COVID patients at a policy level for others who might need it, even in the setting of severe scarcity.
评估社会对体外膜肺氧合(ECMO)作为选择的 2019 冠状病毒病(COVID-19)患者抢救方案的分配偏好。
对全国代表性样本进行横断面调查。
亚马逊土耳其机器人平台。
共纳入来自亚马逊土耳其机器人众包平台的 1041 名成员的回复。参与者年龄为 37.9 ± 12.6 岁,通常为白人(65%),受过大学教育(66.1%)。许多人报告在医疗保健环境中工作(22.5%),有朋友或家人住院(43.8%)或死于 COVID-19(29.9%)。
尽管大多数人表示不愿意在没有恢复迹象的情况下在 ECMO 上维持超过 1 周,但在政策层面上,他们非常支持将 ECMO 作为一种挽救生命的技术使用。大多数人(96.7%)主张在资源匮乏时期继续使用 ECMO 治疗 COVID 患者,但会优先考虑最有可能恢复的患者(50%),其次是无论生存机会如何最病重的患者(31.7%)。40 岁以上的患者更倾向于按先来先服务的原则分配 ECMO(21.5%比 13.3%,p < 0.05)。
尽管参与者在个人情况下对 ECMO 表示犹豫,但他们一致支持在政策层面上使用 ECMO 为其他可能需要它的 COVID 患者治疗,即使在严重短缺的情况下也是如此。